CVS Caremark identified GLP-1 drugs and Humira as points of contention, but the State Health Plan says that mischaracterizes ...

Samsung Bioepis and Organon shared that the Food and Drug Administration has designated the Hadlima (adalimumab-bwwd) high- ...

Lansing's two hospitals and systems are charging very different prices for the same medications, a Michigan Health Purchasers Coalition report shows.

Global trade uncertainty and evolving tariff policies are shifting how bioscience companies view their supply chains.   | ...

In the last month, the FDA has granted interchangeability status to additional adalimumab biosimilars.  Biosimilars with an ...

Humira is a versatile drug used to treat multiple autoimmune diseases, such as rheumatoid arthritis, Crohn’s disease, psoriasis, psoriatic arthritis, ulcerative colitis, and ankylosing spondylitis.

The pharmacy giant manages the prescription drug benefit for the State Health Plan, but contract negotiations are at an impasse.

Sales of Humira – used to treat a long list of diseases, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease – fell by a third to $14.4 billion last year, having been ...

The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.

A large-scale study reveals that rheumatoid arthritis patients—especially those seropositive or on DMARD therapy—face ...

This risk can be mitigated through managing RA and other lifestyle changes. Inflammation in rheumatoid arthritis (RA) primarily affects the joints, but it can also affect other parts of the body.